Xiamen Kingdomway Group Company

Shenzhen Stock Exchange 002626.SZ

Xiamen Kingdomway Group Company Market Capitalization on January 14, 2025: USD 1.19 B

Xiamen Kingdomway Group Company Market Capitalization is USD 1.19 B on January 14, 2025, a -6.08% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Xiamen Kingdomway Group Company 52-week high Market Capitalization is USD 1.47 B on October 28, 2024, which is 24.04% above the current Market Capitalization.
Xiamen Kingdomway Group Company 52-week low Market Capitalization is USD 935.17 M on February 05, 2024, which is -21.09% below the current Market Capitalization.
Xiamen Kingdomway Group Company average Market Capitalization for the last 52 weeks is USD 1.24 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002626.SZ

Xiamen Kingdomway Group Company

CEO	Mr. Bin Jiang
IPO Date	Oct. 28, 2011
Location	China
Headquarters	No. 299 Yangguang West Road
Employees	2,126
Sector	Health Care
Industries Pharmaceuticals Biotechnology Consumer Packaged Goods

Description

Xiamen Kingdomway Group Company engages in the manufacturing and sale of the nutrition and health resources in China and internationally. It offers a series of raw material products, including coenzyme Q10, Vitamin A, Vitamin D3, microalgae DHA, and plant ARA, as well as provides dietary supplements and sports nutrition products. The company was formerly known as Xiamen Jindawei Vitamin Co., Ltd. Xiamen Kingdomway Group Company was founded in 1997 and is based in Xiamen, China.

Key trends

Past 5 years